The effects of two different doses dexmedetomidine after Endotracheal intubatio
Phase 3
- Conditions
- Condition 1: Blood pressure. Condition 2: Heart rate.Elevated blood-pressure reading, without diagnosis of hypertensionTachycardia, unspecifiedR03.0R00.0
- Registration Number
- IRCT20160307026950N15
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Patients candidate Laryngoscopy and Endotracheal intubation
Patients older than 18 yeras old and younger than 65 years old
Patients with American society of anesthesiology physical status class 1,2 (ASAI,II)
Exclusion Criteria
Head and neck masses
Airway malformation
Uncontrollable blood pressure(More than 180/110)
History of cardiovascular disease
History of respiratory disease
allergies to the drugs studied
Body Mass Index greater than 30(BMI>30)
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart rate changes. Timepoint: Before the intervention, 1 ,3, 5, 10 minutes after laryngoscopy. Method of measurement: Heart monitoring.;Systolic blood pressure. Timepoint: Before the intervention, 1 ,3, 5, 10 minutes after laryngoscopy. Method of measurement: Non invasive blood pressure monitor.;Diastolic blood pressure. Timepoint: Before the intervention, 1 ,3, 5, 10 minutes after laryngoscopy. Method of measurement: Non invasive blood pressure monitor.;Mean arterial pressure. Timepoint: Before the intervention, 1 ,3, 5, 10 minutes after laryngoscopy. Method of measurement: Non invasive blood pressure monitor.;Oxygen saturation. Timepoint: Before the intervention, 1 ,3, 5, 10 minutes after laryngoscopy. Method of measurement: Percent with pulse oximeter.;Recovery time. Timepoint: From the end of surgery to full consciousness. Method of measurement: Minute with using a chornometer.
- Secondary Outcome Measures
Name Time Method